NASDAQ · INMB

Inmune Bio, Inc.

Closing price · Nov 13, 2026 $1.05

Latest quarter · ended Sep 30, 2026

Cash got weaker

descriptionFiled Nov 5, 2026
Cash from operationsBetter
−$3.39M
Quarter ended Dec 31, 2024: −$11M cash from operationsQuarter ended Mar 31, 2025: −$6.82M cash from operationsQuarter ended Jun 30, 2025: −$7.38M cash from operationsQuarter ended Sep 30, 2025: −$5.44M cash from operationsQuarter ended Dec 31, 2025: −$2.94M cash from operationsQuarter ended Mar 31, 2026: −$3.4M cash from operationsQuarter ended Jun 30, 2026: −$3.17M cash from operationsQuarter ended Sep 30, 2026: −$3.39M cash from operations
Dec '24Sep '26
vs. −$5.44M a year ago
Share countDiluting
+16.5%
Quarter ended Dec 31, 2024: 22.93M sharesQuarter ended Mar 31, 2025: 23.21M sharesQuarter ended Jun 30, 2025: 26.59M sharesQuarter ended Sep 30, 2025: 26.59M sharesQuarter ended Dec 31, 2025: 26.59M sharesQuarter ended Mar 31, 2026: 26.59M sharesQuarter ended Jun 30, 2026: 27.75M sharesQuarter ended Sep 30, 2026: 30.96M shares
Dec '24Sep '26
30.96M shares vs. 26.59M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 0
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

83 funds report owning INMB, up from 80

Holdings as of Jun 30, 2026
New25
Added23
Held14
Trimmed21
Sold out22

Insider trades · last 12 months

Real buys and sales

No open-market buys or sales by officers or directors in the last 12 months. Hidden: 3 option exercises. Press All filings to see them.

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovOption exercise · Jul 2 · $20.7KOption exercise · Jul 2 · $10.1KOption exercise · Jul 2 · $12.6K
CEOCFOOther officersDirectorsJunJulAugSepOctNovOption exercise · Jul 2 · $20.7KOption exercise · Jul 2 · $10.1KOption exercise · Jul 2 · $12.6K

Last 6 months. A wider screen shows 12.

Showing 0 real trades. Hidden: 3 option exercises. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in INMB

As of Jun 30, 2026
FundOwnsValueChange
Vanguard Capital Management LLC2.3%$1.15M+3%
AQR Capital Management LLC2.1%$1.08M+145%
BlackRock, Inc.1.0%$508K−74%
Raymond James Financial Inc0.7%$347K+5%
Geode Capital Management, LLC0.6%$310K−62%

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast